MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Consideration of the relationship between severity of Parkinson’s disease and cognitive function, depression, quality of life

M. Saruwatari, M. Sagawa, A. Kumon, K. Hasegawa (Sagamihara, Japan)

Meeting: 2017 International Congress

Abstract Number: 1005

Keywords: Depression

Session Information

Date: Wednesday, June 7, 2017

Session Title: Parkinson's Disease: Cognition

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: In this study, we aimed to clarify the relationship between PD severity and cognitive function, depression and quality of life.

Background: We are continuing to examine the cognitive function and mental symptoms of patients with Parkinson’s disease.

Methods: For 107 PD outpatients, we evaluate  MMSE and FAB for cognitive function, SDS for depression, PDQ-39 for QOL.

The subjects were divided into two groups the mild group(Ⅱ or less) and the moderate or severe group(Ⅲ or more)according to Hoehn & Yahr severity classification, and we statistically examined the test results of each group.

Results: There were 50 patients in the mild group.( mean age was 66.7 ± 8.0 years, gender was 20 males, 30 females, and the mean of disease duration was 6.6 ± 6. 9 years.)  There were 57 patients in the moderate or severe group.( mean age was 70.8±8.0 years, gender was 27 males, 30 females, and the mean of disease duration was 5.3±4.6 years.)

Each test mean point and standard deviation of the mild group and the moderate or severe group were written as follows. MMSE: 26.8±2.9,26.2±3.2, FAB: 14.0±2.9,13.6±2.8, SDS: 44.8±7.8,42.0±9.5, PDQ-39: 33.3±28.7,32.8±27.2

As a result of statistically examining the difference in score between the 2 groups, no significant difference was found in any of them (p = .082~.471).

Based on the mean score of each test, in each group, the cognitive function was kept above the cut – off point and the depressed mood was kept within the normal range in many patients.

Conclusions: Regarding cognitive function, depression, quality of life, there was no difference in severity of Parkinson’s disease.  Even if the motor function was impaired by the progression of Parkinson’s disease, it was shown that cognitive function and psychiatric symptoms worsened and QOL did not decrease.

To cite this abstract in AMA style:

M. Saruwatari, M. Sagawa, A. Kumon, K. Hasegawa. Consideration of the relationship between severity of Parkinson’s disease and cognitive function, depression, quality of life [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/consideration-of-the-relationship-between-severity-of-parkinsons-disease-and-cognitive-function-depression-quality-of-life/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/consideration-of-the-relationship-between-severity-of-parkinsons-disease-and-cognitive-function-depression-quality-of-life/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley